Product Information
ASA-BUTALB-CAFF-COD #3 CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.0039 per EA under NDC 69238199301. Its NADAC has been published 354 times since Dec 25, 2019.
FDA first approved this application on Aug 31, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
69238199301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA074951FDA Approved
8/31/1998
TE Code
AB
On Market Since
4/1/2019
Pharmacological Classes
Price Statistics
The NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has been published 354 times since Dec 25, 2019, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0039 per EA |
|---|---|
| All-time high | $1.6451 (Apr 15, 2020) |
| All-time low | $0.7664 (Apr 17, 2024) |
| 52-week high | $1.1684 |
| 52-week low | $0.9392 |
| Median price | $1.1286 |
| Average price | $1.1520 |
| Largest weekly change | +77.7% (Dec 22, 2021) |
| Weeks tracked | 354 |
| Tracking since | Dec 25, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Barbiturate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASA-BUTALB-CAFF-COD #3 CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ASA-BUTALB-CAFF-COD #3 CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.0039 per EA (NDC 69238199301), effective Sep 30, 2026.
How has the price of ASA-BUTALB-CAFF-COD #3 CAPSULE changed over time?
Over the history we have for it, the NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has declined 6.1%. It has been tracked across 354 weekly CMS publications since Dec 25, 2019.
What are the highest and lowest recorded NADAC prices for ASA-BUTALB-CAFF-COD #3 CAPSULE?
Since Dec 25, 2019, the NADAC for ASA-BUTALB-CAFF-COD #3 CAPSULE has ranged from a low of $0.7664 (Apr 17, 2024) to a high of $1.6451 (Apr 15, 2020), with a median of $1.1286 per EA.
Are there cheaper alternatives to ASA-BUTALB-CAFF-COD #3 CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ASA-BUTALB-CAFF-COD #3 CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASA-BUTALB-CAFF-COD #3 CAPSULE?
ASA-BUTALB-CAFF-COD #3 CAPSULE (NDC 69238199301) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.